The ability to specifically target a cell-type is important for the development of vectors for in vivo gene therapy. In order to produce retrovirus vectors targeting ovarian cancer cells, which ...

Recombinant adeno-associated viral vectors (rAAV) have emerged as one of the leading gene transfer systems in human clinical trials. 1 However, rAAV's lack of specificity might lead to off-target ...

Accurate monitoring of nanoparticle size and growth is essential to ensure scalability in the development of transfection vectors for gene delivery. This study highlights how Spatially Resolved-DLS ...

BOSTON--(BUSINESS WIRE)--Kelonia Therapeutics, a biotech company revolutionizing in vivo gene delivery, today announced new preclinical data from its lead program KLN-1010, which will be presented at ...

Researchers in George Mason University’s Center for Infectious Disease Research (CIDR) and Tulane National Primate Research Center conducted a breakthrough proof-of-concept study in Nature’s Gene ...

Exclusive licensing and R&D collaboration accelerate the development of a novel gene vector platform for precision gene therapy in Hepatocellular Carcinoma - the third leading cause of cancer-related ...

Princeton researchers say their two-camera approach offers the most detailed footage of a nano-sized particle to date, which could ultimately shed light on how viruses and cells interact. Elizabeth ...

Tunable red to green emissions in upconversion nanoparticles allow precise identification of single particles, enabling accurate, long-term multicolor tracking in complex live cell environments.